Last filing: May 8, 2026. Most recent sale before this period: Feb 4, 2021. Most recent purchase on record: Nov 24, 2021.
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- Last sale before this period: Feb 4, 2021.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Edwards Lifesciences (EW) | Director | Nov 17, 2014 | May 8, 2026 |
| Johnson & Johnson (JNJ) | Former VP, Strategy & Growth, Director | Sep 10, 2003 | Oct 2, 2009 |
Also a director at
Johnson & Johnson (JNJ) (no filing in the last 18 months)
Recent filings
The last day with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- May 8, 2026, Edwards Lifesciences: 5,127 shares granted. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.